The general aim of the project is to perform a comprehensive genetic characterization of B cell lymphomas using next generation sequencing technologies, with a focus on follicular lymphoma (FL), diffuse large B cell lymphoma (DLBCL) and mantle cell lymphoma (MCL). The study will be performed in close collaboration with clinicians and pathologists and we thus hope it will not only create a unique mutation catalogue/database for B cell lymphoma, but also form a solid basis for future personalized/tailored diagnosis and therapy for our patients.